171 related articles for article (PubMed ID: 8728221)
1. Significance, epidemiology, and prevention of peritoneal dialysis catheter infections.
Burkart JM
Perit Dial Int; 1996; 16 Suppl 1():S340-6. PubMed ID: 8728221
[TBL] [Abstract][Full Text] [Related]
2. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
[TBL] [Abstract][Full Text] [Related]
3. Prevention of peritonitis in children: emerging concepts.
Bakkaloglu SA
Perit Dial Int; 2009 Feb; 29 Suppl 2():S186-9. PubMed ID: 19270214
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal access.
Rodrigues A; Verger C
Contrib Nephrol; 2003; (140):195-201. PubMed ID: 12800360
[No Abstract] [Full Text] [Related]
5. ISPD position statement on reducing the risks of peritoneal dialysis-related infections.
Piraino B; Bernardini J; Brown E; Figueiredo A; Johnson DW; Lye WC; Price V; Ramalakshmi S; Szeto CC
Perit Dial Int; 2011; 31(6):614-30. PubMed ID: 21880990
[No Abstract] [Full Text] [Related]
6. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
7. Complications in peritoneal dialysis: peritonitis and exit-site infections.
Keogh AM
Perit Dial Int; 1996; 16 Suppl 1():S464-7. PubMed ID: 8728246
[No Abstract] [Full Text] [Related]
8. The impact of exit-site care and catheter design on the incidence of catheter-related infections.
Jones LL; Tweedy L; Warady BA
Adv Perit Dial; 1995; 11():302-5. PubMed ID: 8534730
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for peritoneal dialysis-related infections.
Oxton LL; Zimmerman SW; Roecker EB; Wakeen M
Perit Dial Int; 1994; 14(2):137-44. PubMed ID: 8043666
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal dialysis catheter complications.
Bernardini J
Perit Dial Int; 1996; 16 Suppl 1():S468-71. PubMed ID: 8728247
[TBL] [Abstract][Full Text] [Related]
13. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
[No Abstract] [Full Text] [Related]
14. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
[TBL] [Abstract][Full Text] [Related]
15. Potential clinical value of catheters impregnated with antimicrobials for the prevention of infections associated with peritoneal dialysis.
Dukka H; Taal MW; Bayston R
Expert Rev Med Devices; 2023 Jun; 20(6):459-466. PubMed ID: 37138535
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal catheter exit-site and tunnel infections.
Piraino B
Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
19. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
20. Outcome of peritoneal dialysis: Tenckhoff catheter survival in a prospective study.
Ortiz AM; Fernandez MA; Troncoso PA; Guzmán S; Del Campo F; Morales RA
Adv Perit Dial; 2004; 20():145-9. PubMed ID: 15384816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
